Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Effectiveness Study of Single-Port Surgical System in Breast Tumor Surgery

NCT: NCT07879963 · NOT_YET_RECRUITING

NCT IDNCT07879963
StatusNOT_YET_RECRUITING
Start Date2026-10-01
Completion2027-10-01
Sponsorhaiyanli (OTHER)
First posted
Last updated

Brief Summary

This is a prospective, multicenter clinical study designed to evaluate the safety and effectiveness of remote surgery using the single-port thoracoabdominal endoscopic surgical system in breast tumor surgery. Eligible patients diagnosed with breast tumors will receive robotic-assisted remote surgery. The primary endpoints include safety indicators and surgical effectiveness parameters. The study aims to provide clinical evidence for the application of this surgical system in breast cancer treatment.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑